Text Size
- News Releases
- What's New
- 18 Apr
- Nemolizumab Shows Positive Results in Maruho’s Phase 3 Study in Atopic Dermatitis
- 17 Apr
- F. Hoffmann-La Roche Announces First Quarter Sales 2019
- 08 Apr
- Conclusion of Exclusive Licensing and Capital Tie-up Agreements Concerning “Telomelysin (OBP-301),” Oncolytic Viral Immunotherapy
- 01 Apr
- Business Transfer of ULCERLMIN® for the Treatment of Gastritis/Peptic Ulcer from Chugai Pharmaceutical to Fuji Chemical Industries
- 29 Mar
- Chugai - A*STAR Joint Development Project for Anti-Dengue Virus Antibody Continuously Selected as Grant Recipient by GHIT Fund
Video Introduction of CHUGAI- Share this site
